G-Protein Coupled Receptors Market Synopsis

G-Protein Coupled Receptors Market Size Was Valued at USD 3.64 Billion in 2023, and is Projected to Reach USD 5.74 Billion by 2032, Growing at a CAGR of 5.19% From 2024-2032

G-Protein Coupled Receptors abbreviated as GPCRs refer to a monumental family of cell surface transmembrane proteins dimers required for cell signaling. From external stimuli as well as hormones and neurotransmitters on the one hand, and stimuli of the environment on the other, G-proteins helps to carry out intracellular signaling. This interaction triggers a successive chain of cellular response regarding many other concurrent physiological events such as mood, immune response and sensation. Since GPCRs are involved in a wealth of biological processes in living organisms and constitute the foundation of faith of many biologics and drug in modern and future pharmaceutical and biotechnology industry, the G-Protein Coupled Receptors market has importance.

• Currently the market of G-Protein Coupled Receptors (GPCR) which is the large family of receptors play a role in different physiological processes and development of diseases is continuously expanding. Since these GPCRs consists of a large number of membrane receptors and play critical roles in cell signaling, such receptors has become popular targets for medicational purposes. They comprise a largest category of target receptors for drugs in clinic, among one third to one half of marketed drugs are involved. Epidemiological increase in the prevalence of noncommunicable diseases such as cancer, diabetes and cardiovascular diseases among others has led to an advancement in drug synthesis for GPCRs with therapeutic drugs. In addition, growth within the biotechnology including the drugs and drug delivery technologies for instance, high throughput screening and structure based drug activity and discovery, GPCR target drugs are also boosting the market growth.
• Recently the market has has also seen the investment in the development of product as well as the medicine on the basis of genetics and biology. Altogether, due to the recent increase in the quantity of the available information on the GPCR family, the identification of orphan GPCRs has indicated the directions to the creation of drugs. Furthermore, the demand rise of pipeline product related to specific GPCRs emerged from the need to develop novel therapeutic products for unmet market needs. The even more concentrated global attention to emergence of the healthcare business and to the rise of the health care prices especially in the emergent countries should additionally contribute to the even more active expansion of the market with GPCR. On the down side nevertheless, some of the challenges that may constrain the growth of this market include; high costs on research and development, high regulatory frame work and complexities as a result of GPCR signaling pathways. But the GPCR market is anticipated to increase in the future due to development and collaboration of some key players in the GPCR market.

G-Protein Coupled Receptors Market Trend Analysis

Rise in Demand of G-Protein Coupled Receptors (GPCR) Market

• G-protein coupled receptor (GPCR) plays role in controlling numerous physiological activities; thereby, is one of the most pursued targets in medicinal chemistry. It shows how important the interventions are as they make up one third of all drugs today’s generation drug stores. The increasing occurrence of diseases like cancer, diabetes and cardiovascular diseases has helped augment concern for drug targets comprising of GPCRs. Such growth has required more investment from the pharma and the biotechnology firms aspiring to build new therapies that reflect how GPCRs function.
• Besides the advancement in GPCR biology has brought new methods of merely adjusting the receptors which include biased ligands and allosteric ligands which are revolutionary to the conventional drug development. They can provide a better therapeutic profile because of their efficacy and side effects which in turn create numerous therapeutic uses of numerous diseases. Following so much detailed work invested in GPCRs research, one may anticipate GPCR tech-support on signal recognition since they make up this class of GPCRs as learnt from the subsequent literature. The continuous search for more selective GPCR medicines will come a long way to changing the face of the therapeutics and life of patient in the coming years.

The Impact of Personalized Medicine on the GPCR Market

• Custom care has now turned into very popular which has unimaginably impacted the G-Protein Coupled Receptors market particularly through promotion of disease therapeutic remedies that are custom made to correspond with an individual’s genotype. The flexibility which has for some time now being shifted in the management of treatment profiles is a lot helping GPCR-targeted drugs because they are targeting receptors of a given disease or a patient. These are ; CRISPR technology, high through put screening and artificial intelligence; all are helping in identify and refine of the GPCR targeting drugs. These new developments are efficient not only in enhancement of the research but also in providing other productive therapeutic interventions to the complication of diseased circumstances.
• The industry trends are also partnering with academia in enhancing the innovativeness of the GPCR area too. These collaborations are aiding in narrowing the gap between conceptual GPCR functions, which are defined in research and real applications that are expanding the portfolio for enhanced disease therapy. Because the market is an on going process so has been its change in regulation agencies regarding GPCR research and development as a new dimension in scientific area. Because of such an active position, further innovations would be ready for a positive setting and would provide a reference scale in additional therapeutic advancements, targeted at the patient’s comfort, as well as at theShift in current therapies.

G-Protein Coupled Receptors Market Segment Analysis:

G-Protein Coupled Receptors Market Segmented based on By Product, By Assay Type, By Application

By Product, Cell Lines segment is expected to dominate the market during the forecast period

• It is considerably well-known that cell lines are basic apparatuses in biomedical examination that maintain consistence of experiments under certain conditions of the laboratory. They are derived from various tissue sources and it is possible to culture and maintain these lines for relatively long periods This is desirable since most parlance of experiment involves the observation of some of the animals for relatively long periods. Because of the attribute of the higher in vitro viability of cell culture, this is best suited for use within fields such as; drug discovery, the characterization of cell signaling, molecular cancer, study of gene expression and so on this created an environment whereby through a specific cell kind certain aspects of the cellular function could be determined, the reactions to stimuli and the impact of potential therapeutic compounds. For these reasons, cell lines are ideal for the construction of the proliferation of the body of knowledge related to cell functionality and the development of hypothetical disease ideas.
• It is believed that selection of an appropriate cell line is of paramount concern and in fact will to a rather dictate the overall change of an experiment. The facts that are available in the Cellular models of Cultures include; The majority of cell lines are genetically distinct and exhibit unique growth profiles and responses to stimuli, thus various and diverse aspects make the task of interpreting the results of their study as rather complex. Therefore, in choosing the target cell line for investigation, the scientists should also estimate the relevance of the chosen line to a definite system under investigation. A235 strategy of using cell lines that reflect the in viability of the tissue boosts the reality of the results attained and in the long run boost drug discovery and treatment. Another important message that has to be learned when raising in biotechnology is that new and more representative cell lines have to be derived for biomedical use.

By Application, Cancer Research segment held the largest share in 2023

• Oncothereapy is an exciting and interdiscipline scientific field that investigated how cancer and its function during the therapeutic process. Presumably, the specifics of such processes has to be defined in order to identify the diagnostic indexes and the therapy path of the disease. In this respect, a number of products and assays are found closely related to support progressive research work in various ways. Recent developments in upset lines and purchase detection kits afford researcher with capacity to contain analysis of cancerous behaviour such as proliferation, invasion and metastasis. It allows to evaluate the certain subpopulation of cancer stem cell, their interactions with environment and pharmacokinetics.
• In conclusion, the utility of functional assays results a profound insight of the signaling profiles in carcinogenesis and the process of how tumor cells develop resistance to anti-cancer therapy. By using these assays, investigators can analyze how cancer cells commune and respond to changes in their microenvironment: Such action may well be drug treatment for instance or a target therapy. It is valuable when aiming at the enhanced targeting and the personal practice which, maybe, can allow the improvement of the outcomes with the patients. They will continue to espouse the liaison between assay development service and practice of clinical assay as the formation of the basis for future development for additional treatment for cancers including drug resistance and tumour recurrence. Cancer targeting remains as one of the most works in progress but that does not mean that cancer research cannot record tremendous improvement in the future.

G-Protein Coupled Receptors Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• The NA GPCR market in the present world is well developed and is rapidly expanding especially by the advancement of research and development, especially the market in the USA. This area is well developed both in health care system and legal system that is why many global leading pharma firms and biotech organizations are based on the GPCR hunting out the area. This favourable condition not only enhances the rate of new drugs approval but also new idea development to practice hence the research must translate findings into practice shortly. Also, currently increased rates of development of chronic diseases, such as diabetes, cardiovascular and neurological diseases, and so on, have contributed to the need for new therapeutic approaches caused by the characteristics of GPCRs.
• Thus, there seems to be much interaction between academic and industry to enhance the level of innovation in the GPCR market in North America Asia GPCR Entyre organisation has had research relations with the pharmaceutical companies in the market in a bid to better understand GPCR and future of this market in a bid to find drugs. They also facilitate the delivery of knowledge of partners to enable the identification of novel ligands of GPCR and potential targets. Hence, North America continues to be not just the region of the largest improvement in GPCR targeted drugs but also clinical trial and new treatment. That coupled with the continuous technology advancement and the development of a stable and higher funding base for GPCR research work makes the market ready for further developments in the future placing North America as the leading continent in supplying the market leadership for GPCR therapeutics.

Active Key Players in the G-Protein Coupled Receptors Market

• Thermo Fisher Scientific Inc.
• Eurofins Scientific
• QIAGEN
• WuXi AppTec
• Promega Corporation
• Abcam plc
• Merck KGaA
• PerkinElmer Inc
• Enzo Biochem Inc.
• BD
• Other Key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: G-Protein Coupled Receptors Market by Product
 4.1 G-Protein Coupled Receptors Market Snapshot and Growth Engine
 4.2 G-Protein Coupled Receptors Market Overview
 4.3 Cell Lines
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Cell Lines: Geographic Segmentation Analysis
 4.4 Detection Kits
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Detection Kits: Geographic Segmentation Analysis
 4.5 Cell Culture Reagents
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Cell Culture Reagents: Geographic Segmentation Analysis
 4.6 Ligands
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Ligands: Geographic Segmentation Analysis

Chapter 5: G-Protein Coupled Receptors Market by Assay Type
 5.1 G-Protein Coupled Receptors Market Snapshot and Growth Engine
 5.2 G-Protein Coupled Receptors Market Overview
 5.3 cAMP Functional Assays
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 cAMP Functional Assays: Geographic Segmentation Analysis
 5.4 Calcium Functional Assays
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Calcium Functional Assays: Geographic Segmentation Analysis
 5.5 β-Arrestin Functional Assays
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 β-Arrestin Functional Assays: Geographic Segmentation Analysis
 5.6 Radioligand Binding & GTPγS Functional Assays
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Radioligand Binding & GTPγS Functional Assays: Geographic Segmentation Analysis
 5.7 Internalization Assays
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Internalization Assays: Geographic Segmentation Analysis
 5.8 Trafficking Assays
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Trafficking Assays: Geographic Segmentation Analysis
 5.9 Other Assays
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Other Assays: Geographic Segmentation Analysis

Chapter 6: G-Protein Coupled Receptors Market by Application
 6.1 G-Protein Coupled Receptors Market Snapshot and Growth Engine
 6.2 G-Protein Coupled Receptors Market Overview
 6.3 Cancer Research
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Cancer Research: Geographic Segmentation Analysis
 6.4 CNS Research
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 CNS Research: Geographic Segmentation Analysis
 6.5 Metabolic Research
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Metabolic Research: Geographic Segmentation Analysis
 6.6 Cardiovascular Research
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Cardiovascular Research: Geographic Segmentation Analysis
 6.7 Respiratory Research
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Respiratory Research: Geographic Segmentation Analysis
 6.8 Inflammation Research
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Inflammation Research: Geographic Segmentation Analysis
 6.9 Other
  6.9.1 Introduction and Market Overview
  6.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.9.3 Key Market Trends, Growth Factors and Opportunities
  6.9.4 Other: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 G-Protein Coupled Receptors Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 THERMO FISHER SCIENTIFIC INC
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 EUROFINS SCIENTIFIC
 7.4 QIAGEN
 7.5 WUXI APPTEC
 7.6 PROMEGA CORPORATION
 7.7 ABCAM PLC
 7.8 MERCK KGAA
 7.9 PERKINELMER INC
 7.10 ENZO BIOCHEM INC
 7.11 BD
 7.12 OTHER ACTIVE PLAYERS

Chapter 8: Global G-Protein Coupled Receptors Market By Region
 8.1 Overview
 8.2. North America G-Protein Coupled Receptors Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product
  8.2.4.1 Cell Lines
  8.2.4.2 Detection Kits
  8.2.4.3 Cell Culture Reagents
  8.2.4.4 Ligands
  8.2.5 Historic and Forecasted Market Size By Assay Type
  8.2.5.1 cAMP Functional Assays
  8.2.5.2 Calcium Functional Assays
  8.2.5.3 β-Arrestin Functional Assays
  8.2.5.4 Radioligand Binding & GTPγS Functional Assays
  8.2.5.5 Internalization Assays
  8.2.5.6 Trafficking Assays
  8.2.5.7 Other Assays
  8.2.6 Historic and Forecasted Market Size By Application
  8.2.6.1 Cancer Research
  8.2.6.2 CNS Research
  8.2.6.3 Metabolic Research
  8.2.6.4 Cardiovascular Research
  8.2.6.5 Respiratory Research
  8.2.6.6 Inflammation Research
  8.2.6.7 Other
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe G-Protein Coupled Receptors Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product
  8.3.4.1 Cell Lines
  8.3.4.2 Detection Kits
  8.3.4.3 Cell Culture Reagents
  8.3.4.4 Ligands
  8.3.5 Historic and Forecasted Market Size By Assay Type
  8.3.5.1 cAMP Functional Assays
  8.3.5.2 Calcium Functional Assays
  8.3.5.3 β-Arrestin Functional Assays
  8.3.5.4 Radioligand Binding & GTPγS Functional Assays
  8.3.5.5 Internalization Assays
  8.3.5.6 Trafficking Assays
  8.3.5.7 Other Assays
  8.3.6 Historic and Forecasted Market Size By Application
  8.3.6.1 Cancer Research
  8.3.6.2 CNS Research
  8.3.6.3 Metabolic Research
  8.3.6.4 Cardiovascular Research
  8.3.6.5 Respiratory Research
  8.3.6.6 Inflammation Research
  8.3.6.7 Other
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe G-Protein Coupled Receptors Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product
  8.4.4.1 Cell Lines
  8.4.4.2 Detection Kits
  8.4.4.3 Cell Culture Reagents
  8.4.4.4 Ligands
  8.4.5 Historic and Forecasted Market Size By Assay Type
  8.4.5.1 cAMP Functional Assays
  8.4.5.2 Calcium Functional Assays
  8.4.5.3 β-Arrestin Functional Assays
  8.4.5.4 Radioligand Binding & GTPγS Functional Assays
  8.4.5.5 Internalization Assays
  8.4.5.6 Trafficking Assays
  8.4.5.7 Other Assays
  8.4.6 Historic and Forecasted Market Size By Application
  8.4.6.1 Cancer Research
  8.4.6.2 CNS Research
  8.4.6.3 Metabolic Research
  8.4.6.4 Cardiovascular Research
  8.4.6.5 Respiratory Research
  8.4.6.6 Inflammation Research
  8.4.6.7 Other
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific G-Protein Coupled Receptors Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product
  8.5.4.1 Cell Lines
  8.5.4.2 Detection Kits
  8.5.4.3 Cell Culture Reagents
  8.5.4.4 Ligands
  8.5.5 Historic and Forecasted Market Size By Assay Type
  8.5.5.1 cAMP Functional Assays
  8.5.5.2 Calcium Functional Assays
  8.5.5.3 β-Arrestin Functional Assays
  8.5.5.4 Radioligand Binding & GTPγS Functional Assays
  8.5.5.5 Internalization Assays
  8.5.5.6 Trafficking Assays
  8.5.5.7 Other Assays
  8.5.6 Historic and Forecasted Market Size By Application
  8.5.6.1 Cancer Research
  8.5.6.2 CNS Research
  8.5.6.3 Metabolic Research
  8.5.6.4 Cardiovascular Research
  8.5.6.5 Respiratory Research
  8.5.6.6 Inflammation Research
  8.5.6.7 Other
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa G-Protein Coupled Receptors Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product
  8.6.4.1 Cell Lines
  8.6.4.2 Detection Kits
  8.6.4.3 Cell Culture Reagents
  8.6.4.4 Ligands
  8.6.5 Historic and Forecasted Market Size By Assay Type
  8.6.5.1 cAMP Functional Assays
  8.6.5.2 Calcium Functional Assays
  8.6.5.3 β-Arrestin Functional Assays
  8.6.5.4 Radioligand Binding & GTPγS Functional Assays
  8.6.5.5 Internalization Assays
  8.6.5.6 Trafficking Assays
  8.6.5.7 Other Assays
  8.6.6 Historic and Forecasted Market Size By Application
  8.6.6.1 Cancer Research
  8.6.6.2 CNS Research
  8.6.6.3 Metabolic Research
  8.6.6.4 Cardiovascular Research
  8.6.6.5 Respiratory Research
  8.6.6.6 Inflammation Research
  8.6.6.7 Other
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America G-Protein Coupled Receptors Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product
  8.7.4.1 Cell Lines
  8.7.4.2 Detection Kits
  8.7.4.3 Cell Culture Reagents
  8.7.4.4 Ligands
  8.7.5 Historic and Forecasted Market Size By Assay Type
  8.7.5.1 cAMP Functional Assays
  8.7.5.2 Calcium Functional Assays
  8.7.5.3 β-Arrestin Functional Assays
  8.7.5.4 Radioligand Binding & GTPγS Functional Assays
  8.7.5.5 Internalization Assays
  8.7.5.6 Trafficking Assays
  8.7.5.7 Other Assays
  8.7.6 Historic and Forecasted Market Size By Application
  8.7.6.1 Cancer Research
  8.7.6.2 CNS Research
  8.7.6.3 Metabolic Research
  8.7.6.4 Cardiovascular Research
  8.7.6.5 Respiratory Research
  8.7.6.6 Inflammation Research
  8.7.6.7 Other
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research